I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Ulrik B. Nielsen net worth and biography

Ulrik Nielsen Biography and Net Worth

Director of Merrimack Pharmaceuticals

Ulrik B. Nielsen, Ph.D. has served as a member of our board of directors since January 2015 and is one of our co-founders. Dr. Nielsen led our research and drug discovery in various roles from when he joined us in 2002 to January 2015, including as our Senior Vice President and Chief Scientific Officer from March 2009 until January 2015. Dr. Nielsen has been President and Chief Executive Officer of Tidal Therapeutics, Inc., a biotechnology company, since August 2018. Dr. Nielsen previously served in various capacities at Torque Therapeutics Inc., a biotechnology company, including as President from January 2015 to June 2018, Founder Chairman from November 2017 to June 2018 and Chief Executive Officer from January 2015 to November 2017. Dr. Nielsen also served as Chief Executive Officer of Silver Creek Pharmaceuticals, Inc., a former majority owned subsidiary of ours, from July 2010 to March 2014. Dr. Nielsen also currently serves on the board of directors of Alloy Therapeutics LLC. Dr. Nielsen holds a Ph.D. in molecular biology and an M.S. in biochemistry from the University of Copenhagen. We believe that Dr. Nielsen is qualified to serve on our board of directors due to his extensive knowledge of Merrimack, his leadership and management experience at Merrimack and other biotechnology companies, and his thorough understanding of our business and industry.

What is Ulrik B. Nielsen's net worth?: The estimated net worth of Ulrik B. Nielsen is at least $344,676.53 as of September 14th, 2017. Dr. Nielsen owns 22,781 shares of Merrimack Pharmaceuticals stock worth more than $344,677 as of November 2nd. This net worth estimate does not reflect any other investments that Dr. Nielsen may own. Additionally, Dr. Nielsen receives a salary of $72,500.00 as Director at Merrimack Pharmaceuticals. Learn More about Ulrik B. Nielsen's net worth.
How old is Ulrik B. Nielsen?: Dr. Nielsen is currently 52 years old. There are 3 older executives and no younger executives at Merrimack Pharmaceuticals. The oldest executive at Merrimack Pharmaceuticals is Dr. Anthony J. Sinskey Ph.D., Sc.D., Co-Founder and Scientific Advisor, who is 84 years old. Learn More on Ulrik B. Nielsen's age.
What is Ulrik B. Nielsen's salary?: As the Director of Merrimack Pharmaceuticals, Inc., Dr. Nielsen earns $72,500.00 per year. The highest earning executive at Merrimack Pharmaceuticals is Mr. Gary L. Crocker M.B.A., President, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman, who commands a salary of $76,000.00 per year. Learn More on Ulrik B. Nielsen's salary.
How do I contact Ulrik B. Nielsen?: The corporate mailing address for Dr. Nielsen and other Merrimack Pharmaceuticals executives is ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA, 02142. Merrimack Pharmaceuticals can also be reached via phone at 617-720-8606 and via email at [email protected]. Learn More on Ulrik B. Nielsen's contact information.
Has Ulrik B. Nielsen been buying or selling shares of Merrimack Pharmaceuticals?: Ulrik B. Nielsen has not been actively trading shares of Merrimack Pharmaceuticals in the last ninety days. Most recently, on Monday, January 24th, Ulrik B. Nielsen bought 14,287 shares of Merrimack Pharmaceuticals stock. The stock was acquired at an average cost of $4.24 per share, with a total value of $60,576.88. Learn More on Ulrik B. Nielsen's trading history.
Who are Merrimack Pharmaceuticals' active insiders?: Merrimack Pharmaceuticals' insider roster includes Eric Andersen (Director), Gary Crocker (Insider), Noah Levy (Director), and Ulrik Nielsen (Director). Learn More on Merrimack Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Merrimack Pharmaceuticals?: In the last twelve months, Merrimack Pharmaceuticals insiders bought shares 5 times. They purchased a total of 201,070 shares worth more than $2,581,121.40. The most recent insider tranaction occured on December, 28th when Director Eric Andersen bought 857 shares worth more than $11,440.95. Insiders at Merrimack Pharmaceuticals own 30.6% of the company. Learn More about insider trades at Merrimack Pharmaceuticals.
Information on this page was last updated on 12/28/2023.

Ulrik B. Nielsen Insider Trading History at Merrimack Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/24/2022	Buy	14,287	$4.24	$60,576.88
9/15/2017	Sell	7,896	$14.23	$112,360.08	22,781
9/14/2017	Sell	100	$14.20	$1,420.00	22,781
9/13/2017	Sell	21,556	$14.40	$310,406.40	37,437
9/11/2017	Sell	14,756	$14.46	$213,371.76	37,437
7/20/2015	Sell	20,000	$10.71	$214,200.00
6/19/2015	Sell	40,000	$12.02	$480,800.00
5/19/2015	Sell	40,000	$13.04	$521,600.00
4/20/2015	Sell	40,000	$12.88	$515,200.00
3/19/2015	Sell	40,000	$11.97	$478,800.00
2/23/2015	Sell	20,000	$10.91	$218,200.00

Ulrik B. Nielsen Buying and Selling Activity at Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Company Overview

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $15.13

$15.13

50 Day Range

MA: $14.82

$14.65

$15.13

2 Week Range

Now: $15.13

$11.53

$15.89

Volume

N/A

Average Volume

396,929 shs

Market Capitalization

$223.77 million

P/E Ratio

1.09

Dividend Yield

N/A

Beta

1.45

True paradigm shift

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Ulrik Nielsen Biography and Net Worth

What is Ulrik B. Nielsen's net worth?

How old is Ulrik B. Nielsen?

What is Ulrik B. Nielsen's salary?

How do I contact Ulrik B. Nielsen?

Has Ulrik B. Nielsen been buying or selling shares of Merrimack Pharmaceuticals?

Who are Merrimack Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Merrimack Pharmaceuticals?